Company: APXIF
Filing Date: 2025-07-18
Form Type: F-4/A
Source: 0001213900-25-065703
Chunk: 284

Company: APx Acquisition Corp. I
Filing Date: 2025-07-18
Form: F-4/A
Chunk 284
---
 action in the ordinary course of business consistent with past practices. On March 5, 2024, Linklaters sent a revised draft of the Business Combination Agreement to Greenberg, proposing a SPAC Transaction Expense Cap of $6,650,000 and a definition for “Executive -levelEmployee” as individuals employed by the Company whose annual base salary exceeds $100,000. On March 6, 2024, Greenberg circulated comments to the Business Combination Agreement to Linklaters, refining the provisions related to the equity compensation plans of MultiplAI. Later that day, Linklaters circulated comments to the Business Combination Agreement, reducing the SPAC Transaction Expense Cap to $6,150,000. On March 7, 2024, Greenberg circulated comments to the Business Combination Agreement to Linklaters, increasing the SPAC Transaction Expense Cap to $6,630,759, incorporating additional intellectual property covenants, such as the transfer of the domain name “www.heritas.com.ar” to the Company, for no consideration, and the transfer of “MultiplAI Health” trademark to MultiplAI for no consideration. On March 8, 2024, Linklaters circulated comments to the Business Combination Agreement to Greenberg and, later that day, Greenberg provided additional comments to the Business Combination Agreement. Key changes included (i) reduction of the SPAC transaction Expenses Cap from $6,630,759 to $5,880,759, and (ii) the addition to the fully paid “tail” directors’ and officers’ liability insurance policy as a component of the “Company Transaction Expenses.” From March 14, 2024 to March 21, 2024, Linklaters and Greenberg exchanged drafts of the Business Combination Agreement. Key changes included the inclusion of any necessary filings or approvals under applicable antitrust or competition laws, such as Argentine Law No. 27,442 ( Ley de Defensa de la Competencia) as a condition precedent to Closing, and additional cleanup changes. On March 18, 2024, the Company received a Certificate of Incorporation on Change Name from the Registrar of Companies of the Cayman Islands, changing its name to OmnigenicsAI Corp. On March19, 2024, Greenberg circulated to Linklaters a draft of the Business Combination Agreement, reflecting the name change to OmnigenicsAI Corp and cleanup changes. On March20, 2024, Linklaters and Greenberg exchanged drafts of the Business Combination Agreement